Technology & Innovation

As the “Technoking” of Tesla strategizes to maintain his control over the company’s decision-making, anyone concerned with the role that Tesla will play in the evolving EV transition should be asking how CEO Musk might use, or abuse, his powerful position.

The IRA has the potential to rectify the imbalance between public benefit and private incentives

Patrick Gelsinger stepped down as INTEL’s CEO on December 1. We published an analysis last August that provides context for why this is significant for the company and the US economy.

Cybersecurity expert Muayyad Al-Chalabi assesses CrowdStrike’s update failure and its broader implications for cybersecurity in a discussion with Lynn Parramore.

Increasing evidence that the IRA is probably not harming pharmaceutical innovation.

Sensitivity of investment and valuation to drug price indices and market conditions

New technologies appear to yield long-lasting benefits for the pioneer locations where they were originally developed.

The concentration of innovation in a handful of urban centers engenders large and persistent regional disparities in economic opportunity.

The $48 Billion Stock-Option Package and its Implications for the EV Transition

An ensemble of mechanisms enables cloud hegemons (Microsoft, Google, Amazon) to plan the whole AI knowledge and innovation network by weaponizing interdependence in networks.

Industry lobbyists vehemently oppose Medicare drug price negotiations. However, physician-scientist Fred Ledley and economist William Lazonick debunk their arguments.

India: Climate Change, Technology, and Growth

Reindustrialization vs Financialization

In his new book, Let Them Eat Crypto, Peter Howson cautions that the technologies are not just fraudulent but causing indefensible harm to both humanity and the planet.

The famed short-seller talks Sam Bankman-Fried, why Wall Street is still so keen on crypto, and how technology is making us dumber.